Abonnement à la biblothèque: Guest
Critical Reviews™ in Eukaryotic Gene Expression

Publication de 6  numéros par an

ISSN Imprimer: 1045-4403

ISSN En ligne: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Lessons from Osteopetrotic Mutations in Animals: Impact on Our Current Understanding of Osteoclast Biology

Volume 15, Numéro 2, 2005, pp. 133-162
DOI: 10.1615/CritRevEukaryotGeneExpr.v15.i2.40
Get accessGet access

RÉSUMÉ

Throughout life, bone tissue is in a constant state of turnover. This process of bone remodeling is the result of a combination of sequential removal of bone tissue by osteoclasts and new bone deposition by osteoblasts. The osteopetroses are a heterogeneous group of skeletal disorders characterized by a generalized increase in bone mass caused by decreased bone resorption. Over the past decade, major contributions to our current knowledge on bone resorption have been made by studies of osteopetrotic mutations in animals. A considerable heterogeneity among the various osteopetrotic animals is observed, showing that a multiplicity of mutations may cause osteopetrosis. This review focuses on the spontaneous and experimentally induced osteopetrotic mutations in animals. We will discuss their impact on our current understanding of osteoclast biology and we will correlate, when possible, the animal models of osteopetroses to diseases in humans.

CITÉ PAR
  1. Segovia-Silvestre T., Neutzsky-Wulff A. V., Sorensen M. G., Christiansen C., Bollerslev J., Karsdal M. A., Henriksen K., Advances in osteoclast biology resulting from the study of osteopetrotic mutations, Human Genetics, 124, 6, 2009. Crossref

  2. Askmyr Maria K., Fasth Anders, Richter Johan, Towards a better understanding and new therapeutics of osteopetrosis, British Journal of Haematology, 140, 6, 2008. Crossref

  3. Van Wesenbeeck Liesbeth, Odgren Paul R., Coxon Fraser P., Frattini Annalisa, Moens Pierre, Perdu Bram, MacKay Carole A., Van Hul Els, Timmermans Jean-Pierre, Vanhoenacker Filip, Jacobs Ruben, Peruzzi Barbara, Teti Anna, Helfrich Miep H., Rogers Michael J., Villa Anna, Van Hul Wim, Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans, Journal of Clinical Investigation, 117, 4, 2007. Crossref

  4. Mazzolari Evelina, Forino Concetta, Razza Alessia, Porta Fulvio, Villa Anna, Notarangelo Luigi Daniele, A single-center experience in 20 patients with infantile malignant osteopetrosis, American Journal of Hematology, 84, 8, 2009. Crossref

  5. Villa Anna, Guerrini Matteo M., Cassani Barbara, Pangrazio Alessandra, Sobacchi Cristina, Infantile Malignant, Autosomal Recessive Osteopetrosis: The Rich and The Poor, Calcified Tissue International, 84, 1, 2009. Crossref

  6. Del Fattore Andrea, Cappariello Alfredo, Teti Anna, Genetics, pathogenesis and complications of osteopetrosis, Bone, 42, 1, 2008. Crossref

  7. Van Hul Wim, Sclerosing bone disorders: a lot of knowns but still some unknowns, BoneKEy Reports, 1, 6, 2012. Crossref

  8. Peruzzi Barbara, Teti Anna, The Physiology and Pathophysiology of the Osteoclast, Clinical Reviews in Bone and Mineral Metabolism, 10, 2, 2012. Crossref

  9. Ross F. Patrick, Osteoclasts, in Vitamin D, 2011. Crossref

  10. Helfrich Miep H, Crockett Julie C, Hocking Lynne J, Coxon Fraser P, The pathogenesis of osteoclast diseases: Some knowns, but still many unknowns, BoneKEy-Osteovision, 4, 2, 2007. Crossref

  11. Alam Imranul, Gray Amie K., Chu Kang, Ichikawa Shoji, Mohammad Khalid S., Capannolo Marta, Capulli Mattia, Maurizi Antonio, Muraca Maurizio, Teti Anna, Econs Michael J., Del Fattore Andrea, Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models, Bone, 59, 2014. Crossref

  12. Perdu Bram, Van Hul Wim, Sclerosing Bone Disorders, in Genetics of Bone Biology and Skeletal Disease, 2013. Crossref

  13. Brommage Robert, Genetic Approaches To Identifying Novel Osteoporosis Drug Targets, Journal of Cellular Biochemistry, 116, 10, 2015. Crossref

  14. Wen Xin, Lacruz Rodrigo S., Paine Michael L., Dental and Cranial Pathologies in Mice Lacking the Cl−/H+-Exchanger ClC-7, The Anatomical Record, 298, 8, 2015. Crossref

  15. Alshowaeir Daniah, Ajlan Abdulrazag, Hussain Sajjad, Alsuhaibani Adel, Visual Function Improvement After Optic Nerve Sheath Fenestration in Osteopetrosis Patients with Optic Canal Stenosis: A Report of Two Cases, Neuro-Ophthalmology, 42, 3, 2018. Crossref

  16. Rajan I., Read R., Small D. L., Perrard J., Vogel P., An Alternative Splicing Variant in Clcn7–/– Mice Prevents Osteopetrosis but Not Neural and Retinal Degeneration, Veterinary Pathology, 48, 3, 2011. Crossref

  17. Boudin Eveline, Van Hul Wim, Sclerosing Bone Disorders, in Genetics of Bone Biology and Skeletal Disease, 2018. Crossref

  18. Sobacchi Cristina, Schulz Ansgar, Coxon Fraser P., Villa Anna, Helfrich Miep H., Osteopetrosis: genetics, treatment and new insights into osteoclast function, Nature Reviews Endocrinology, 9, 9, 2013. Crossref

  19. Johansson Maria K., de Vries Teun J., Schoenmaker Ton, Ehinger Mats, Brun Ann C. M., Fasth Anders, Karlsson Stefan, Everts Vincent, Richter Johan, Hematopoietic stem cell–targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice, Blood, 109, 12, 2007. Crossref

  20. Masi Laura, Falchetti Alberto, Brandi Maria Luisa, Genetica dell’osteoporosi, dell’osteopetrosi e dell’osteogenesi imperfetta, in Osteoporosi e malattie metaboliche dell’osso, 2009. Crossref

  21. Villa Anna, Helfrich Miep, Sobacchi Cristina, Osteopetrosis, in Stiehm's Immune Deficiencies, 2020. Crossref

  22. Chellaiah Meenakshi A., Moorer Megan C., Majumdar Sunipa, Aljohani Hanan, Morley Sharon C., Yingling Vanessa, Stains Joseph P., L-Plastin deficiency produces increased trabecular bone due to attenuation of sealing ring formation and osteoclast dysfunction, Bone Research, 8, 1, 2020. Crossref

  23. Liu Wei, Di Qianqian, Li Kailun, Li Jing, Ma Ning, Huang Zhibin, Chen Jiahao, Zhang Sheng, Zhang Wenqing, Zhang Yiyue, The synergistic role of Pu.1 and Fms in zebrafish osteoclast-reducing osteopetrosis and possible therapeutic strategies, Journal of Genetics and Genomics, 47, 9, 2020. Crossref

  24. Manzi Giovanni, Romanò Delia, Moneghini Laura, Romanò Carlo L, Successful staged hip replacement in septic hip osteoarthritis in osteopetrosis: a case report, BMC Musculoskeletal Disorders, 13, 1, 2012. Crossref

  25. Teti Anna, Econs Michael J., Osteopetroses, emphasizing potential approaches to treatment, Bone, 102, 2017. Crossref

Prochains articles

PRMT6 promotes the immune evasion of gastric cancer via upregulating ANXA1 Liang Xu, Fenger Zhang, Binqi Yu, Shengnan Jia, Sunfu Fan PURPL promotes M2 macrophage polarization in lung cancer via regulating RBM4/xCT signaling Jipeng Guo, Chongwen Gong, Hao Wang SIAH1 promotes the pyroptosis of cardiomyocytes in diabetic cardiomyopathy via regulating IκB-α/NF-κB signaling Jinbin Wu, Yaoming Yan SLC7A2-mediated lysine catabolism inhibits immunosuppression in triple negative breast cancer Yuanyuan Sun, Yaqing Li, Chengying Jiang, Chenying Liu, Yuanming Song SIAH2-mediated degradation of ACSL4 inhibits the anti-tumor activity of CD8+ T cells in hepatocellular carcinoma Fangzheng Shu, Yuhua Shi, Xiangxiang Shan, Wenzhang Zha, Rengen Fan, Wanjiang Xue RBM15-mediated N6-methyl adenosine (m6A) modification of EZH2 drives the epithelial-mesenchymal transition of cervical cancer Ruixue Wang, Wenhua Tan Evidence-Based Storytelling and A Strategic Roadmap to Promote Cancer Prevention Via Adolescent HPV Vaccination in Northern New England Matthew Dugan, Gary Stein, Jan Carney, Sheila Clifford-Bova KDM4A-AS1 promotes cell proliferation, migration and invasion via the miR-4306/STX6 axis in hepatocellular carcinoma Wei Cao, Yuhan Ren, Ying Liu, Guoshu Cao, Zhen Chen, Fan Wang HDAC1-mediated downregulation of NEU1 exacerbates the aggressiveness of cervical cancer Nanzi Xie, Sisi Mei, Changlan Dai, Wei Chen Effect of miR-26b-5p on progression of acute myeloid leukemia by regulating USP48-mediated Wnt/β-catenin pathway Yu Xie, Lin Tan, Kun Wu, Deyun Li, Chengping Li
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain